USNA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

220.79M

+3.36%

0.400

-37.5%

223.55M

-10.42%

0.400

-45.21%

224.13M

-4.97%

0.440

-40.54%

Estimates Revision

The market is revising Upward the revenue expectations for USANA Health Sciences, Inc. (USNA) for FY2025, with the revenue forecasts being adjusted by 0.03% over the past three months. During the same period, the stock price has changed by -23.74%.

Revenue Estimates for FY2025

Revise Upward

+0.03%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.76%

In Past 3 Month

Stock Price

Go Down

-23.74%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for USANA Health Sciences Inc (USNA.N) is 11.17, compared to its 5-year average forward P/E of 17.42. For a more detailed relative valuation and DCF analysis to assess USANA Health Sciences Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

17.42

Current PE

11.17

Overvalued PE

21.57

Undervalued PE

13.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

6.73

Current EV/EBITDA

2.56

Overvalued EV/EBITDA

9.34

Undervalued EV/EBITDA

4.12

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.16

Current PS

0.40

Overvalued PS

1.57

Undervalued PS

0.75

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

USNA News & Events

Events Timeline

No data

News

2.0

01-05PRnewswire

USANA's Kevin Guest Advocates Growth Mindset for 2026 Success

2.0

01-05Newsfilter

USANA's Kevin Guest Advocates Growth Mindset for Lasting Success

7.5

2025-12-23PRnewswire

USANA Foundation Delivers 5,143 Food Bags to Support Children During Winter Break

People Also Watch

Frequently Asked Questions

What is USANA Health Sciences Inc (USNA) stock price today?

The current price of USNA is 20.01 USD — it has increased 2.25 % in the last trading day.

What is USANA Health Sciences Inc (USNA)'s business?

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

What is the price predicton of USNA Stock?

Wall Street analysts forecast USNA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for USNA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is USANA Health Sciences Inc (USNA)'s revenue for the last quarter?

USANA Health Sciences Inc revenue for the last quarter amounts to 213.67M USD, increased 6.72 % YoY.

What is USANA Health Sciences Inc (USNA)'s earnings per share (EPS) for the last quarter?

USANA Health Sciences Inc. EPS for the last quarter amounts to -0.36 USD, decreased -164.29 % YoY.

What changes have occurred in the market's expectations for USANA Health Sciences Inc (USNA)'s fundamentals?

How many employees does USANA Health Sciences Inc (USNA). have?

USANA Health Sciences Inc (USNA) has 1700 emplpoyees as of January 09 2026.

What is USANA Health Sciences Inc (USNA) market cap?

Today USNA has the market capitalization of 357.76M USD.